A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KNTE shares is 129, representing 98.90% of the company's common stock.

BlackRock Fund Advisors, in the last quarter, reduced its stake in KNTE by -1.87% restricting it's holding to 1.68 Million shares of worth nearly $10.23 Million. Citadel Advisors LLC also lessened -4.55% of the KNTE shares from its portfolio, reducing its holding to 1.05 Million shares of worth $6.38 Million. N/A also shunned KNTE shares holding by N/A last quarter which brought its holding to 0 shares worth $0.

As per its latest 13F filing, RA Capital Management LP increased its stake in KNTE by 0% in the last quarter. The institutional holder raised its holding to 4.26 Million shares having worth more than $26.01 Million. Fidelity Management & Research Co also added 10.82% more shares of KNTE to its portfolio, raising its holding to 2.42 Million shares of worth $14.79 Million. Lynx1 Capital Management LP also increased its KNTE shares holding by 32.16% which brought its holding to 2.21 Million shares worth $13.5 Million.

The insider with the most stakes in KNTE is GORDON CARL L , a Director at the company. Additionally, KNTE stock is highly held by Chief Medical Officer WILLIAMS RICHARD THOMAS and N/A N/A among others.

Company executives, directors, and other insiders own 0.4 percent of Kinnate Biopharma Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which KNTE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include

There have been no transaction(s) during the past 6-months in which KNTE insiders have bought stock N/A.

Around 176.6 Thousands Kinnate Biopharma Inc. shares are held by insiders, which represents about 0.40% of KNTE Stock.

KNTE Director, GORDON CARL L holds the largest portfolio of the company's shares. KNTE shares owned by Levinson total nearly 3.51 Million.

RA Capital Management LP is the largest institutional owner in KNTE which holds 4.26 Million shares worth $26.01 Million or 9.65% of the total KNTE shares outstanding followed by Fidelity Management & Research Co with ownership of 2.42 Million shares representing 5.49% of the KNTE ownership. Lynx1 Capital Management LP, Inc is the third largest stakeholder with 2.21 Million shares or 5.01% of the ownership worth more than $13.5 Million.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KNTE is concerned, it is a stock which is optionable.

Number of KNTE shares short as of 2022-10-13 was 3.51 Million. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 44.15 Million shares of KNTE are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KNTE has 43.94 Million shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KNTE was N/A as of 2022-10-13.